| EPC388 | Low uptake of exposure-influenced HIV testing among a sample of pre/post-exposure prophylaxis (PrEP/PEP) naïve young men who have sex with men in two U.S. cities: implication for targeted interventions | E-poster | HIV testing to support prevention |
| EPE138 | 'Low PrEP knowledge and high interest among men living with HIV in rural South Africa | E-poster | Innovations and lessons for supporting HIV prevention effective use and treatment adherence |
| EPB158 | Low level of virologic failure and resistance in ART-experienced, integrase inhibitor-naïve participants receiving dolutegravir (DTG) and Nucleoside Reverse Transcriptase Inhibitors (NRTIs) combined regimens: 10-year follow-up in the SAILING Study | E-poster | ART in highly treatment-experienced persons |
| EPB124 | Low incidence of adverse drug reactions associated with generic-equivalent antiretroviral product substitutions in a publicly-funded HIV treatment program | E-poster | Other ART complications and adverse reactions |
| PESUB14 | Low frequency of activated T cells in people living with HIV, aviremic under treatment, and presenting neurocognitive disorders | Poster exhibition | Neurologic disorders (e.g. CNS malignancies) |
| EPC016 | Low birth weight among infants born to women living with HIV and HIV-uninfected women at CA-IeDEA sites in Rwanda | E-poster | Epidemiology of HIV in women |
| EPC261 | Low awareness of pre-exposure prophylaxis among female sex workers in Togo | E-poster | HIV prevention services for key populations |
| EPE306 | Lost to HIV care in the context of deep-rooted inequities in Winnipeg, MB, Canada | E-poster | Systems serving underserved populations |
| EPC431 | Loss to follow-up in HIV care: Issues in retention and re-engagement among People Living with HIV (PLHIV) in 13 African countries | E-poster | Strategies to improve re-engagement |
| EPC465 | Lopinavir/Ritonavir post-exposure prophylaxis did not protect against Covid-19 | E-poster | COVID-19 prevention |